Contents

Current Medicinal Chemistry, Volume 18 - Number 20

Irreversible Protein Kinase Inhibitors

, 18(20): 2981 - 2994

L. Garuti, M. Roberti and G. Bottegoni


DOI: 10.2174/092986711796391705




ATP-Competitive Inhibitors of mTOR: An Update

, 18(20): 2995 - 3014

S. Schenone, C. Brullo, F. Musumeci, M. Radi and M. Botta


DOI: 10.2174/092986711796391651




Targeting the Human DEAD-Box Polypeptide 3 (DDX3) RNA Helicase as a Novel Strategy to Inhibit Viral Replication

, 18(20): 3015 - 3027

A. Garbelli, M. Radi, F. Falchi, S. Beermann, S. Zanoli, F. Manetti, U. Dietrich, M. Botta and G. Maga


DOI: 10.2174/092986711796391688




The Potential Role of Glycogen Synthase Kinase 3 Inhibitors as Amyotrophic Lateral Sclerosis Pharmacological Therapy

, 18(20): 3028 - 3034

V. Palomo, D. I. Perez, C. Gil and A. Martinez


DOI: 10.2174/092986711796391697




Biological Potential and Structure-Activity Relationships of Most Recently Developed Vascular Disrupting Agents: An Overview of New Derivatives of Natural Combretastatin A-4

, 18(20): 3035 - 3081

M. Marrelli, F. Conforti, G. A. Statti, X. Cachet, S. Michel, F. Tillequin and F. Menichini


DOI: 10.2174/092986711796391642




Current Progress in Antifibroitcs

, 18(20): 3082 - 3092

S. A.A. El Bialy, K. F. Abd El Kader and M. B. El-Ashmawy


DOI: 10.2174/092986711796391679




Bone Metastatic Disease: Taking Aim at New Therapeutic Targets

, 18(20): 3093 - 3115

F. Coluzzi, E. Di Bussolo, I. Mandatori and C. Mattia


DOI: 10.2174/092986711796391660




Managing the Liabilities Arising from Structural Alerts: A Safe Philosophy for Medicinal Chemists

, 18(20): 3116 - 3135

P. J. Edwards and C. Sturino


DOI: 10.2174/092986711796391714




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science